United States · FDA National Drug Code directory
MIPLYFFA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72542-162_18850625-1a1d-4351-862e-5d46b08eb978
- Product NDC
- 72542-162
- Form
- CAPSULE
- Composition / generic term
- arimoclomol citrate
- Labeler
- Acer Therapeutics Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240920
- Source listing expiry
- 20271231
Source-listed ingredients
- ARIMOCLOMOL CITRATE — 62 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (72542-162-01) / 90 CAPSULE in 1 BOTTLE · 72542-162-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →